Case Reports in Oncology

Scope & Guideline

Advancing Oncology Through Case Studies

Introduction

Welcome to your portal for understanding Case Reports in Oncology, featuring guidelines for its aims and scope. Our guidelines cover trending and emerging topics, identifying the forefront of research. Additionally, we track declining topics, offering insights into areas experiencing reduced scholarly attention. Key highlights include highly cited topics and recently published papers, curated within these guidelines to assist you in navigating influential academic dialogues.
LanguageEnglish
ISSN1662-6575
PublisherKARGER
Support Open AccessYes
CountrySwitzerland
TypeJournal
Convergefrom 2010 to 2024
AbbreviationCASE REP ONCOL / Case Rep. Oncol.
Frequency3 issues/year
Time To First Decision-
Time To Acceptance-
Acceptance Rate-
Home Page-
AddressALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND

Aims and Scopes

The journal 'Case Reports in Oncology' is dedicated to publishing detailed case reports that contribute to the understanding of oncology practices, therapeutic approaches, and patient outcomes. The journal serves as a platform for the dissemination of unique and rare cancer cases, highlighting novel therapeutic strategies, emerging treatment modalities, and significant clinical observations in oncology.
  1. Case Reports of Rare Cancers:
    The journal emphasizes the importance of documenting unusual cancer presentations and rare malignancies, providing valuable insights into their clinical management and treatment.
  2. Innovative Treatment Approaches:
    It highlights case reports that explore new treatment modalities, including targeted therapies, immunotherapies, and combination regimens, showcasing their efficacy and safety in various cancer types.
  3. Multidisciplinary Perspectives:
    The journal encourages submissions that reflect a multidisciplinary approach to cancer care, integrating input from medical oncologists, surgeons, radiologists, and pathologists.
  4. Patient Outcomes and Follow-ups:
    The focus is on detailed follow-up of patients post-treatment, providing data on long-term outcomes, recurrence rates, and survival, which are crucial for improving clinical practices.
  5. Emerging Genetic and Molecular Insights:
    The journal includes case reports that delve into the genetic and molecular underpinnings of cancers, enhancing the understanding of tumor biology and potential targeted therapies.
The landscape of oncology is constantly evolving, and the journal 'Case Reports in Oncology' reflects this dynamism through its increasing focus on various emerging themes and trends. These trends highlight the advancements in oncology and the innovative approaches being adopted in clinical practice.
  1. Immunotherapy and Targeted Therapies:
    There is a significant rise in case reports documenting the use of immunotherapy and targeted therapies, showcasing their effectiveness and expanding the therapeutic options available to patients.
  2. Personalized Medicine:
    Emerging themes include case reports that focus on personalized treatment approaches based on genetic testing and molecular profiling, highlighting the shift towards tailored cancer therapy.
  3. Combination Therapies:
    The journal increasingly features reports on novel combination therapies, illustrating the trend towards integrating various treatment modalities for enhanced efficacy.
  4. Long-Term Follow-Up Studies:
    A growing number of submissions emphasize long-term follow-up and outcomes, reflecting the importance of understanding the durability of treatment responses and late effects.
  5. Real-World Evidence and Patient Experiences:
    There is a trend towards incorporating real-world evidence and patient-reported outcomes in case reports, providing insights into the practical implications of treatments in everyday clinical settings.

Declining or Waning

While the journal continues to thrive in several areas, certain themes have shown a declining interest in recent publications. This may reflect shifts in clinical practice, research focus, or the availability of newer methodologies.
  1. Traditional Chemotherapy Case Reports:
    There has been a noticeable decrease in case reports focusing solely on traditional chemotherapy treatments, as the oncology field increasingly emphasizes targeted therapies and immunotherapy.
  2. Standard Surgical Techniques:
    Case reports detailing standard surgical approaches without new insights or innovations are becoming less common, as the focus shifts towards minimally invasive procedures and novel surgical techniques.
  3. Palliative Care Cases:
    The frequency of case reports centered on palliative care alone has diminished, possibly due to a growing emphasis on curative and transformative therapies in oncology.
  4. Common Cancer Types:
    Reports on well-known malignancies, such as breast and lung cancer, without unique angles or significant clinical insights are less frequently submitted, indicating a preference for more complex or rare cases.
  5. Historical Treatment Comparisons:
    There is a decline in the publication of case reports comparing historical treatment regimens, as the field rapidly evolves and focuses on contemporary practices.

Similar Journals

Hematology Reports

Unlocking the future of hematology research.
Publisher: MDPIISSN: 2038-8322Frequency: 4 issues/year

Hematology Reports is an esteemed academic journal in the field of hematology, dedicated to advancing the understanding of blood disorders and their treatment. Published by MDPI, a leading Swiss publisher known for its commitment to open access since 2009, this journal provides a valuable platform for researchers and healthcare professionals to disseminate innovative findings and foster collaboration within the academic community. The journal features an array of articles ranging from clinical studies to laboratory research, and is indexed in Scopus, where it currently holds a rank of 113 out of 137 in the Medicine - Hematology category, placing it in the 17th percentile. As an open-access journal, Hematology Reports ensures that critical research is accessible to a global audience, supporting the dissemination of knowledge that has the potential to improve patient outcomes. This journal is an essential resource for those engaged in the study and treatment of hematological conditions, encouraging dialogue and the exchange of ideas to enhance clinical practices.

Translational Oncology

Innovating Tomorrow's Cancer Therapies Today
Publisher: ELSEVIER SCIENCE INCISSN: 1936-5233Frequency: 6 issues/year

Translational Oncology is a premier open access journal published by Elsevier Science Inc, dedicated to the rapidly evolving field of cancer research and oncology. Since its inception in 2008, the journal has been a vital platform for the dissemination of innovative research and findings that bridge the gap between laboratory discoveries and clinical applications. With an impressive impact factor and ranked Q2 in Cancer Research and Q1 in Oncology, it occupies a prominent position in the academic landscape, helping to shape the future of cancer therapeutics and patient care. The journal offers valuable insights across a diverse array of topics, including molecular biology, genetic factors in cancer, and innovative treatment strategies, ensuring relevance and engagement for its readership. As it converges toward 2024, Translational Oncology continues to attract a global audience of researchers, healthcare professionals, and students committed to advancing our understanding of cancer and enhancing clinical outcomes.

CHEMOTHERAPY

Exploring Breakthroughs in Drug Discovery and Oncology
Publisher: KARGERISSN: 0009-3157Frequency: 4 issues/year

CHEMOTHERAPY, published by KARGER, is a premier academic journal established in 1960, dedicated to disseminating cutting-edge research and advancements in the fields of drug discovery, infectious diseases, oncology, and pharmacology. With an impressive Scopus ranking placing it in the Q2 category for major disciplines such as Drug Discovery and Infectious Diseases, this journal provides an invaluable platform for researchers and professionals aiming to explore new therapeutic approaches and methodologies. Located in the heart of Switzerland, its publications are a key resource for anyone looking to stay informed about the latest developments and trends in the pharmacological sciences. Researchers can benefit from its diverse scope while contributing to a growing body of knowledge that emphasizes the importance of effective chemotherapeutic strategies in modern medicine. Despite not being an Open Access journal, CHEMOTHERAPY remains committed to maintaining a rigorous peer-review process, ensuring the highest quality of published work.

Case Reports in Gastrointestinal Medicine

Innovating patient care with critical clinical insights.
Publisher: HINDAWI LTDISSN: 2090-6528Frequency: 1 issue/year

Case Reports in Gastrointestinal Medicine, published by HINDAWI LTD, is a leading open-access journal dedicated to the dissemination of significant findings in the field of gastrointestinal medicine. Established in 2011, this journal champions the accessibility of scholarly work, allowing researchers, professionals, and students to explore vital case studies that enhance clinical understanding and patient care across various gastrointestinal conditions. With an emphasis on innovative practices and advances in treatment, the journal serves as an invaluable resource for those committed to furthering their knowledge and improving outcomes in gastrointestinal health. By promoting the robust sharing of case reports and clinical insights, Case Reports in Gastrointestinal Medicine not only contributes to the academic community but also supports practitioners in their quest for evidence-based practice.

Medical Mycology Case Reports

Advancing fungal research through real-world insights.
Publisher: ELSEVIERISSN: 2211-7539Frequency:

Medical Mycology Case Reports, published by Elsevier, is a pivotal journal dedicated to advancing the field of mycology through the presentation of case reports that highlight clinical findings, diagnostic challenges, and treatment outcomes associated with fungal infections. With its ISSN 2211-7539 and E-ISSN 2211-7539, this open-access journal has been serving the global community since 2012, allowing unrestricted access to its valuable insights. Situated in the Netherlands, specifically at RADARWEG 29, AMSTERDAM, this journal has gained recognition in areas such as Infectious Diseases (ranked Q3) and Microbiology (ranked Q4) as of 2023. Its commitment to disseminating high-quality research is reflected in its Scopus rankings, which place it at the 51st percentile in Medicine and the 32nd percentile in Immunology and Microbiology. By bridging the gap between clinical cases and academic research, Medical Mycology Case Reports plays a crucial role in enriching the knowledge base of practitioners and researchers alike, ultimately contributing to improved patient management and public health.

ACG Case Reports Journal

Transforming Patient Care with Innovative Gastrointestinal Research
Publisher: LIPPINCOTT WILLIAMS & WILKINSISSN: Frequency: 12 issues/year

ACG Case Reports Journal, published by Lippincott Williams & Wilkins, is a pivotal resource in the realm of gastrointestinal medicine and clinical practice. Since its inception in 2014, this open-access journal has dedicated itself to disseminating high-quality case reports that contribute to the evolving understanding of gastrointestinal diseases and their management. With an impressive ranking of #203 out of 529 in the General Medicine category according to Scopus, placing it in the 61st percentile, the journal underscores its significant role in advancing medical knowledge. This accessibility allows researchers, healthcare professionals, and students to engage with groundbreaking case studies, enriching their expertise and promoting informed clinical decision-making. ACG Case Reports Journal aims to foster a collaborative environment where innovative ideas and clinical experiences converge, ultimately enhancing patient care and outcomes in the field of gastroenterology.

International Cancer Conference Journal

Leading the Charge Against Cancer Through Knowledge
Publisher: SPRINGER INT PUBL AGISSN: 2192-3183Frequency: 4 issues/year

International Cancer Conference Journal, published by Springer International Publishing AG, serves as a pivotal platform for the dissemination of cutting-edge research in the field of oncology. With a commitment to advancing the understanding, prevention, and treatment of cancer, this journal offers a forum for the presentation of innovative studies, clinical trials, and comprehensive reviews that cater to the needs of researchers, healthcare professionals, and students alike. Although currently not open access, the journal is dedicated to fostering collaboration and knowledge sharing within the cancer research community. The ISSN for this journal is 2192-3183, ensuring its listing within prominent academic databases for enhanced visibility. Hailing from Switzerland, the journal aspires to impact the global dialogue on cancer through rigorous peer-reviewed articles and special conference proceedings, making it an essential resource for those dedicated to the fight against cancer.

AME Case Reports

Connecting the Medical Community with Essential Case Reports
Publisher: AME PUBLISHING COMPANYISSN: 2523-1995Frequency: 4 issues/year

AME Case Reports, published by AME PUBLISHING COMPANY, is a peer-reviewed open-access journal dedicated to the dissemination of high-quality clinical case reports across various medical disciplines. With an expanding focus on innovative medical practices and clinical experiences, this journal serves as an essential platform for healthcare professionals, researchers, and medical students to share significant findings and insights that contribute to evidence-based practices. Although specific metrics such as impact factors and H-index are not currently available, the journal's commitment to academic rigor and accessibility fosters an environment for scholarly exchange and professional development. The publication facilitates immediate access to important case studies that may inform clinical decisions and improve patient care. In an era where sharing specialized knowledge is paramount, AME Case Reports stands as a vital resource for those involved in the medical community worldwide.

Current Problems in Cancer: Case Reports

Exploring unique clinical scenarios in cancer care.
Publisher: ELSEVIERISSN: 2666-6219Frequency: 2 issues/year

Current Problems in Cancer: Case Reports is a prominent scholarly journal published by Elsevier, focusing on critical case reports within the field of oncology. Since its transition to Open Access in 2020, it has enhanced accessibility for researchers and healthcare professionals seeking to share and discuss unique clinical scenarios and insights that advance cancer treatment and patient care. Operating from the United States, this journal aims to address the important and often intricate challenges faced in oncology, facilitating a platform for knowledge exchange and the exploration of new perspectives in cancer management. Despite its current Q4 category ranking in the 2023 oncology category of Scopus with a rank of #359/404, its goal is to enrich the academic discourse by featuring diverse case reports and promoting evidence-based practices. As the journal evolves from 2021 to 2024, it seeks to impact the field by inviting researchers, professionals, and students to contribute their findings, ultimately fostering a collaborative environment for tackling the complexities of cancer.

Internal Medicine

Bridging Research and Practice in Internal Medicine
Publisher: JAPAN SOC INTERNAL MEDICINEISSN: 0918-2918Frequency: 12 issues/year

Internal Medicine is a distinguished peer-reviewed journal published by the Japan Society of Internal Medicine, focusing on the nuanced field of internal medicine. Since its inception in 1974 and with a commitment to advancing medical knowledge, the journal has evolved remarkably, aiming to disseminate high-quality research that contributes to the understanding and treatment of internal diseases. Operating from Tokyo, Japan, it provides an intellectual platform for researchers and clinicians to publish original articles, reviews, and case studies that address various aspects of internal medicine. The journal currently holds a ranking in the Q3 quartile for both Internal Medicine and miscellaneous Medicine categories as of 2023, signifying its growing influence in the medical community. Although not an open-access journal, it remains accessible to a wide audience through institutional subscriptions, enhancing its reach among professionals and students alike. With its commitment to excellence, Internal Medicine serves as an essential resource for those seeking the latest developments and research within this vital medical field.